Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-29T10:32:37.594Z Has data issue: false hasContentIssue false

Characteristics of Adults Hospitalized for a Major Depressive Disorder: Results from the Multicenter OASIS-D Study

Published online by Cambridge University Press:  19 July 2023

C. U. Correll*
Affiliation:
Child and Adolescent Psychiatry, Charite Universitaetsmedizin, Campus Virchow-Klinikum
F. Bermpohl
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus St. Hedwig Hospital
N. Schoofs
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus St. Hedwig Hospital, Berlin
R. Bathe-Peters
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus St. Hedwig Hospital, Berlin
K. Pfeifer
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus St. Hedwig Hospital, Berlin
P. Falkai
Affiliation:
Clinic for Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich
C. Schüle
Affiliation:
Clinic for Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich
F. Pan-Montojo
Affiliation:
Clinic for Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich
E. Y. M. Wang
Affiliation:
Clinic for Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich
A. Reif
Affiliation:
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main
C. Reif-Leonhard
Affiliation:
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main
S. Schillo
Affiliation:
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main
P. Getty
Affiliation:
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main
M. Adli
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus Mitte, Berlin
R. Papenfuß
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus Mitte, Berlin
F. Jessen
Affiliation:
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne
F. Salimi-Dafsari
Affiliation:
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne
M. Bauer
Affiliation:
Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Dresden
U. Lewitzka
Affiliation:
Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Dresden
C. Otte
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus Benjamin Franklin, Berlin
L. Graumann
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus Benjamin Franklin, Berlin
D. Piber
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus Benjamin Franklin, Berlin
S. Weyn-Banningh
Affiliation:
Department of Psychiatry and Psychotherapy, Charite Universitaetsmedizin, Campus Benjamin Franklin, Berlin
A. Meyer-Lindenberg
Affiliation:
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
A. Böhringer
Affiliation:
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
F. Heuer
Affiliation:
Child and Adolescent Psychiatry, Charite Universitaetsmedizin, Campus Virchow-Klinikum
V. B. Nöhles
Affiliation:
Child and Adolescent Psychiatry, Charite Universitaetsmedizin, Campus Virchow-Klinikum
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Major Depressive Disorder (MDD) is one of the most common mental illnesses worldwide and is strongly associated with suicidality. Commonly used treatments for MDD with suicidality include crisis intervention, oral antidepressants (although risk of suicidal behavior is high among non-responders and during the first 10-14 days of the treatment) benzodiazepines and lithium. Although several interventions addressing suicidality exist, only few studies have characterized in detail patients with MDD and suicidality, including treatment, clinical course and outcomes. Patient Characteristics, Validity of Clinical Diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D)-study is an investigator-initiated trial funded by Janssen-Cilag GmbH.

Objectives

For population 1 out of 3 OASIS-D populations, to assess the sub-population of patients with suicidality and its correlates in hospitalized individuals with MDD.

Methods

The ongoing OASIS-D study consecutively examines hospitalized patients at 8 German psychiatric university hospitals treated as part of routine clinical care. A sub-group of patients with persistent suicidality after >48 hours post-hospitalization are assessed in detail and a sub-group of those are followed for 6 months to assess course and treatment of suicidality associated with MDD. The present analysis focuses on a preplanned interim analysis of the overall hospitalized population with MDD.

Results

Of 2,049 inpatients (age=42.5±15.9 years, females=53.2%), 68.0% had severe MDD without psychosis and 21.2% had moderately severe MDD, with 16.7% having treatment-resistant MDD. Most inpatients referred themselves (49.4%), followed by referrals by outpatient care providers (14.6%), inpatient care providers (9.0%), family/friends (8.5%), and ambulance (6.8%). Of these admissions, 43.1% represented a psychiatric emergency, with suicidality being the reason in 35.9%. Altogether, 72.4% had at least current passive suicidal ideation (SI, lifetime=87.2%), including passive SI (25.1%), active SI without plan (15.5%), active SI with plan (14.2%), and active SI with plan+intent (14.1%), while 11.5% had attempted suicide ≤2 weeks before admission (lifetime=28.7%). Drug-induced mental and behavioral disorders (19.6%) were the most frequent comorbid disorders, followed by personality disorders (8.2%). Upon admission, 64.5% were receiving psychiatric medications, including antidepressants (46.7%), second-generation antipsychotics (23.0%), anxiolytics (11.4%) antiepileptics (6.0%), and lithium (2.8%). Altogether, 9.8% reported nonadherence to medications within 6 months of admission.

Conclusions

In adults admitted for MDD, suicidality was common, representing a psychiatric emergency in 35.9% of patients. Usual-care treatments and outcomes of suicidality in hospitalized adults with MDD require further study.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.